International Diabetes Federation awards $2 million to 9 global diabetes research projects

February 10, 2010

Nine new diabetes research projects will be funded for a total of US$2 million over the next three years as part of the International Diabetes Federation's (IDF) translational research grant programme, BRIDGES.

A total of 157 applications were considered for the second round of funding. The chosen projects address important issues in primary and secondary prevention of diabetes in different parts of the world.

"BRIDGES is a key programme for IDF's work and mission. The support of translational research projects is critical in a world facing various global health challenges, including diabetes," said IDF President Jean Claude Mbanya.

"Just like the first phase, this round of the programme has a true global impact. The research carried out will have far reaching implications in Austria, China, Colombia, Haiti, India, the Philippines, South Africa and the US," Prof Mbanya added.

The projects focus on topics such as lifestyle intervention to prevent type 2 diabetes, gestational diabetes, peer support, foot inspection for the visually impaired and the impact of motivational interviewing.
-end-
A full description of each project is available at http://www.idfbridges.org

For more information, contact

Nancy Matos
Communications Officer, International Diabetes Federation
Email: nancy.matos@idf.org
Tel: +32-2-543-1639
Mobile: +32-492817785

Note to editors:

The International Diabetes Federation (IDF) is the global advocate for more than 285 million people with diabetes worldwide. It represents over 200 diabetes associations in more than 160 countries. Its mission is to promote diabetes care, prevention and a cure worldwide. IDF is in official relations with the World Health Organization and associated with the United Nations Department of Public Information. Visit /www.idf.org for details.

BRIDGES or Bringing Research in Diabetes to Global Environments and Systems is the global grant programme of the International Diabetes Federation supported by an educational grant from Eli Lilly and Company. It provides funding for translational research pilot projects and outcome studies over the course of seven years. Relevant topics include methods and strategies to improve health care delivery to people with and at risk of diabetes; enhance diabetes self management; promote healthy lifestyles or lifestyle change to reduce the risk of diabetes; and identify people with pre-diabetes and undiagnosed diabetes in cost-effective ways. Visit www.idfbridges.org for more information on the grant selection process.

International Diabetes Federation

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.